274 related articles for article (PubMed ID: 20149460)
1. A novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene, in hyper-IgE syndrome.
Papanastasiou AD; Mantagos S; Papanastasiou DA; Zarkadis IK
Mol Immunol; 2010 Apr; 47(7-8):1629-34. PubMed ID: 20149460
[TBL] [Abstract][Full Text] [Related]
2. Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups.
Jiao H; Tóth B; Erdos M; Fransson I; Rákóczi E; Balogh I; Magyarics Z; Dérfalvi B; Csorba G; Szaflarska A; Megarbane A; Akatcherian C; Dbaibo G; Rajnavölgyi E; Hammarström L; Kere J; Lefranc G; Maródi L
Mol Immunol; 2008 Nov; 46(1):202-6. PubMed ID: 18706697
[TBL] [Abstract][Full Text] [Related]
3. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome.
Minegishi Y; Saito M; Tsuchiya S; Tsuge I; Takada H; Hara T; Kawamura N; Ariga T; Pasic S; Stojkovic O; Metin A; Karasuyama H
Nature; 2007 Aug; 448(7157):1058-62. PubMed ID: 17676033
[TBL] [Abstract][Full Text] [Related]
4. Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency.
Minegishi Y; Karasuyama H
Int Immunol; 2009 Feb; 21(2):105-12. PubMed ID: 19088064
[TBL] [Abstract][Full Text] [Related]
5. Hyper-IgE syndrome.
Minegishi Y
Curr Opin Immunol; 2009 Oct; 21(5):487-92. PubMed ID: 19717292
[TBL] [Abstract][Full Text] [Related]
6. A novel mutation in the linker domain of the signal transducer and activator of transcription 3 gene, p.Lys531Glu, in hyper-IgE syndrome.
Kim HJ; Kim JH; Shin YK; Lee SI; Ahn KM
J Allergy Clin Immunol; 2009 Apr; 123(4):956-8. PubMed ID: 19348930
[No Abstract] [Full Text] [Related]
7. Clinical features, STAT3 gene mutations and Th17 cell analysis in nine children with hyper-IgE syndrome in mainland China.
Zhang LY; Tian W; Shu L; Jiang LP; Zhan YZ; Liu W; Zhao XD; Cui YX; Tang XM; Wang M; Wu DQ; Yang XQ
Scand J Immunol; 2013 Sep; 78(3):258-65. PubMed ID: 23659370
[TBL] [Abstract][Full Text] [Related]
8. Hyper IgE (Job's) syndrome: a primary immune deficiency with oral manifestations.
Freeman AF; Domingo DL; Holland SM
Oral Dis; 2009 Jan; 15(1):2-7. PubMed ID: 19036057
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of the immunological abnormalities in hyper-IgE syndrome.
Minegishi Y; Saito M
Ann N Y Acad Sci; 2011 Dec; 1246():34-40. PubMed ID: 22236428
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis.
Schimke LF; Sawalle-Belohradsky J; Roesler J; Wollenberg A; Rack A; Borte M; Rieber N; Cremer R; Maass E; Dopfer R; Reichenbach J; Wahn V; Hoenig M; Jansson AF; Roesen-Wolff A; Schaub B; Seger R; Hill HR; Ochs HD; Torgerson TR; Belohradsky BH; Renner ED
J Allergy Clin Immunol; 2010 Sep; 126(3):611-7.e1. PubMed ID: 20816194
[TBL] [Abstract][Full Text] [Related]
11. [Hyper-IgE recurrent infection syndrome: pathogenesis, diagnosis and therapeutic management].
Guisado Vasco P; Fraile Rodríguez G; Arechaga Uriarte S
Rev Clin Esp; 2011 Nov; 211(10):520-6. PubMed ID: 21700278
[TBL] [Abstract][Full Text] [Related]
12. Hyperimmunoglobulin E syndrome with a novel STAT3 mutation.
Anolik R; Elmariah S; Lehrhoff S; Votava HJ; Martiniuk FT; Levis W
Dermatol Online J; 2009 Aug; 15(8):16. PubMed ID: 19891924
[TBL] [Abstract][Full Text] [Related]
13. Blood CD4+CD45RO+CXCR5+ T cells are decreased but partially functional in signal transducer and activator of transcription 3 deficiency.
Mazerolles F; Picard C; Kracker S; Fischer A; Durandy A
J Allergy Clin Immunol; 2013 Apr; 131(4):1146-56, 1156.e1-5. PubMed ID: 23403044
[TBL] [Abstract][Full Text] [Related]
14. Reduced memory B cells in patients with hyper IgE syndrome.
Speckmann C; Enders A; Woellner C; Thiel D; Rensing-Ehl A; Schlesier M; Rohr J; Jakob T; Oswald E; Kopp MV; Sanal O; Litzman J; Plebani A; Pietrogrande MC; Franco JL; Espanol T; Grimbacher B; Ehl S
Clin Immunol; 2008 Dec; 129(3):448-54. PubMed ID: 18835223
[TBL] [Abstract][Full Text] [Related]
15. STAT3 single-nucleotide polymorphisms and STAT3 mutations associated with hyper-IgE syndrome are not responsible for increased serum IgE serum levels in asthma families.
Wjst M; Lichtner P; Meitinger T; Grimbacher B
Eur J Hum Genet; 2009 Mar; 17(3):352-6. PubMed ID: 18841165
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of chemoattractant receptors by polymorphonuclear leukocytes in Hyper IgE Syndrome patients.
Mintz R; Garty BZ; Meshel T; Marcus N; Katanov C; Cohen-Hillel E; Ben-Baruch A
Immunol Lett; 2010 May; 130(1-2):97-106. PubMed ID: 20005258
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel STAT3 mutation in a patient with hyper-IgE syndrome.
Mogensen TH; Jakobsen MA; Larsen CS
Scand J Infect Dis; 2013 Mar; 45(3):235-8. PubMed ID: 22992060
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous manifestations of Hyper IgE syndrome.
Minegishi Y; Saito M
Allergol Int; 2012 Jun; 61(2):191-6. PubMed ID: 22441639
[TBL] [Abstract][Full Text] [Related]
19. [Dominant negative STAT-3 mutations in hyper-IgE syndrome].
Dereure O
Ann Dermatol Venereol; 2008 May; 135(5):432. PubMed ID: 18457738
[No Abstract] [Full Text] [Related]
20. Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation.
Bittner TC; Pannicke U; Renner ED; Notheis G; Hoffmann F; Belohradsky BH; Wintergerst U; Hauser M; Klein B; Schwarz K; Schmid I; Albert MH
Klin Padiatr; 2010 Nov; 222(6):351-5. PubMed ID: 21058221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
